Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03199404 · ClinicalTrials.gov registry record
Trevo Aspiration Proximal Flow Control Registry
A clinical trial, sponsored by University of Massachusetts, Worcester.
- Terminated
- Registry status
- 38
- Enrollment target
NCT03199404: Clinical Trial study, sponsored by University of Massachusetts, Worcester.
NCT03199404 is a clinical trial that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03199404 was terminated before completion, sponsored by University of Massachusetts, Worcester.
- TERMINATED
- Registry status
- 38 participants
- Enrollment target
Study Summary
This purpose of this retrospective, single-arm, non-randomized, multi-center study is to collect real-world data on the effectiveness of using the TRAP technique in acute ischemic stroke patients undergoing mechanical thrombectomy.
Primary Outcome
Revascularization as assessed via Thrombolysis in Cerebral Infarction (TICI) score (TICI 2b/3) in affected vessels
Interventions
- DEVICE TRAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2019-10-03 |
Why NCT03199404 stopped before completion
NCT03199404 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which TRAP is the first listed.
NCT03199404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03199404 about?
NCT03199404 is a clinical study titled "Trevo Aspiration Proximal Flow Control Registry". This purpose of this retrospective, single-arm, non-randomized, multi-center study is to collect real-world data on the effectiveness of using the TRAP technique in acute ischemic stroke patients undergoing mechanical thrombectomy.
What is the current status of trial NCT03199404?
This trial is currently terminated. The enrollment target is 38 participants. The study started on 2017-06-06. Estimated completion is 2019-10-03.
What interventions are being tested in trial NCT03199404?
The interventions under investigation include: TRAP (DEVICE).
Who is sponsoring clinical trial NCT03199404?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI